09:01 AM EDT, 06/29/2026 (MT Newswires) -- Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) advancing by 0.4%.

BridgeBio Pharma ( BBIO ) stock was up more than 3% after the company said it met the primary endpoint in a phase 3 trial of the oral drug infigratinib, for the treatment of children living with achondroplasia, or bone dwarfism.